Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial

BMC Psychiatry

Hiroto Ito³  Yoshio Hirayasu¹  Toshie Noda³  Hana Hasegawa¹  Naoya Sugiyama¹  Yasuyuki Okumura²  Mio Ishii³ 

[1] Numazu Chuo Hospital, 24-1 Nakase-cho, Numazu, Shizuoka 410-8575, Japan;Research Department, Institute for Health Economics and Policy, Association for Health Economics Research and Social Insurance and Welfare, 1-5-11 Nishishimbashi, Minato-ku, Tokyo 105-0003, Japan;Department of Social Psychiatry, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan

关键词: Study protocol;    Randomised controlled trial;    Patient satisfaction;    Shared decision making;    Schizophrenia;   

Others  :  1123640
DOI  :  10.1186/1471-244X-14-111

 received in 2014-02-17, accepted in 2014-04-03,  发布年份 2014

【 摘 要 】

Background

Shared decision making is a promising model for patient-centred medicine, resulting in better clinical outcomes overall. In the mental health field, interventions that consider the patient-centred perspective—such as patient quality of life, involvement in the treatment, treatment satisfaction, and working alliance—have increased and better clinical outcomes discovered for patients with schizophrenia. However, few studies have examined the efficacy of shared decision making for schizophrenia treatment. The objective of this study is to evaluate the effect of a shared decision making intervention compared to treatment as usual on patient satisfaction at discharge for first-admission patients with schizophrenia.

Methods/Design

This is a randomised, parallel-group, two-arm, open-label, single-centre study currently being conducted in an acute psychiatric ward of Numazu Chuo Hospital, Japan. We are recruiting patients between 16 and 65 years old who are admitted to the ward with a diagnosis of schizophrenia without prior experience of psychiatric admission. Fifty-eight participants are being randomised into a shared decision making intervention group or a treatment as usual control group in a 1:1 ratio. The intervention program was developed based on a shared decision making model and is presented as a weekly course lasting the duration of the patients’ acute psychiatric ward stay. The primary outcome measure is patient satisfaction at discharge as assessed by the Client Satisfaction Questionnaire. Due to the study’s nature, neither the patient nor staff can be blinded.

Discussion

This is the first randomised controlled trial to evaluate the efficacy of shared decision making for patients with early-treatment-stage schizophrenia. The intervention program in this study is innovative in that it includes both of the patient and staff who are involved in the treatment.

Trial registration

The study has been registered with ClinicalTrials.gov as NCT01869660.

【 授权许可】

   
2014 Ishii et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 4.

【 参考文献 】

• [1]Laine C, Davidoff F: Patient-centered medicine. A professional evolution. JAMA 1996, 275:152-156.
• [2]Truog RD: Patients and doctors–evolution of a relationship. N Engl J Med 2012, 366:581-585.
• [3]Charles C, Gafni A, Whelan T: Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997, 44:681-692.
• [4]Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R: Decision aids for people facing health treatment or screening decisions. Cochrane database Syst Rev 2011, 10:CD001431. http://www.ncbi.nlm.nih.gov/pubmed/21975733 webcite
• [5]Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatr 2002, 63:892-909.
• [6]Zygmunt A, Olfson M, Boyer CA, Mechanic D: Interventions to improve medication adherence in schizophrenia. Am J Psychiatr 2002, 159:1653-1664.
• [7]Nosé M, Barbui C, Gray R, Tansella M: Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatr 2003, 183:197-206.
• [8]Schulz M, Gray R, Spiekermann A, Abderhalden C, Behrens J, Driessen M: Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial. Schizophr Res 2013, 146:59-63.
• [9]Maneesakorn S, Robson D, Gournay K, Gray R: An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs 2007, 16:1302-1312.
• [10]Gray R, Leese M, Bindman J, Becker T, Burti L, David A, Gournay K, Kikkert M, Koeter M, Puschner B, Schene A, Thornicroft G, Tansella M: Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatr 2006, 189:508-514.
• [11]Anderson KH, Ford S, Robson D, Cassis J, Rodrigues C, Gray R: An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. Int J Ment Health Nurs 2010, 19:340-349.
• [12]De Haan L, van Amelsvoort T, Dingemans P, Linszen D: Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up. Pharmacopsychiatry 2007, 40:264-268.
• [13]Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C: Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatr 2005, 62:717-724.
• [14]Junghan UM, Leese M, Priebe S, Slade M: Staff and patient perspectives on unmet need and therapeutic alliance in community mental health services. Br J Psychiatr 2007, 191:543-547.
• [15]Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S: Shared decision making for in-patients with schizophrenia. Acta psychiatrica Scandinavica 2006, 114:265-273.
• [16]Hamann J, Mendel R, Meier A, Asani F, Pausch E, Leucht S, Kissling W: “How to speak to your psychiatrist”: shared decision-making training for inpatients with schizophrenia. Psychiatr Serv 2011, 62:1218-1221.
• [17]Van der Krieke L, Emerencia AC, Boonstra N, Wunderink L, de Jonge P, Sytema S: A Web-Based Tool to Support Shared Decision Making for People With a Psychotic Disorder: Randomized Controlled Trial and Process Evaluation. J Med Internet Res 2013, 15:e216.
• [18]Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962, 10:799-812.
• [19]Miyata R, Fujii Y, Inagaki A: Reliability of the Japanese version of Brief Psychiatric Rating Scales (BPRS) [in Japanese]. Rinsho Hyoka 1995, 23:357-367.
• [20]Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD: Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979, 2:197-207.
• [21]Tachimori H, Ito H: Reliability and validity of the Japanese version of Client Satisfaction Questionnaire. Seishin Igaku (Clin Psychiatr) 1999, 41:711-717.
• [22]Priebe S, McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rössler W, Salize H, Svensson B, Torres-Gonzales F, van den Brink R, Wiersma D, Wright DJ: Structured patient-clinician communication and 1-year outcome in community mental healthcare: cluster randomised controlled trial. Br J Psychiatr 2007, 191:420-426.
• [23]Huguelet P, Mohr S, Betrisey C, Borras L, Gillieron C, Marie AM, Rieben I, Perroud N, Brandt P-Y: A randomized trial of spiritual assessment of outpatients with schizophrenia: patients’ and clinicians' experience. Psychiatr Serv 2011, 62:79-86.
• [24]Ito H, Shingai N, Yamazumi S, Sawa Y, Iwasaki S: Patient Perceptions and Satisfaction of Psychiatric Services at their Discharge. Psychiatr Neurol Jpn 1999, 101:138-147.
• [25]Hogan TP, Awad AG, Eastwood R: A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983, 13:177-183.
• [26]Miyata R, Fujii Y, Inagaki A, Yagi G: Psychophardmacology for the patients with schizophrenia and their quality of life (QOL): Assessment using the Japanese version of Drug Attitude Inventory (DAI). (abstract) (in Japanese). Seishin Shinkeigaku Zasshi 1996, 98:1045-1046.
• [27]Loh A, Simon D, Wills CE, Kriston L, Niebling W, Härter M: The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns 2007, 67:324-332.
• [28]Buuren S: Flexible Imputation of Missing Data. Boca Raton, FL: Chapman and Hall/CRC Press; 2012:342. ISBN 9781439868249
• [29]Martin DJ, Garske JP, Davis MK: Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol 2000, 68:438-450.
• [30]Duncan E, Best C, Hagen S: Shared decision making interventions for people with mental health conditions. Cochrane database Syst Rev 2010, 1:CD007297. http://www.ncbi.nlm.nih.gov/pubmed/20091628 webcite